ADIL Stock Summary and Trading Ideas (Adial Pharmaceuticals | NASDAQ:ADIL)

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Adial Pharmaceuticals trades on the NASDAQ stock market under the symbol ADIL.

As of March 29, 2023, ADIL stock price was flat at $0.37 with 55,482 million shares trading.

ADIL has a beta of -0.49, meaning it tends to be less sensitive to market movements. ADIL has a correlation of 0.01 to the broad based SPY ETF.

ADIL has a market cap of $10.47 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ADIL stock traded as high as $5.08 and as low as $.20.

The top ETF exchange traded funds that ADIL belongs to (by Net Assets): VXF, IWC.

ADIL has underperformed the market in the last year with a price return of -81.4% while the SPY ETF lost -10.6%. However, in the short term, ADIL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +66.9% vs +7.0% return in SPY. But in the last 2 weeks, ADIL shares have been beat by the market, returning -9.8% compared to an SPY return of +2.8%.

ADIL support price is $.33 and resistance is $.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADIL stock will trade within this expected range on the day.